Apollo Hospitals Share Price in Focus; Gets CCI Nod to Acquire 30.58% Stake in Apollo Health

Apollo Hospitals Enterprise Limited has informed the stock exchanges about a key update relating to a proposed transaction involving its healthcare subsidiary.  

Details of the Proposed Acquisition 

The Board of Directors of Apollo Hospitals Enterprise Limited, at its meeting held on 12 September 2025, approved the acquisition of 41,650,368 equity shares, representing a 30.58% equity stake, in its subsidiary Apollo Health and Lifestyle Limited (AHLL).  

The shares are being acquired from the International Finance Corporation, Washington (IFC) and IFC EAF Apollo Investment Company (IFC EAF) for a total consideration of ₹12,540.68 million. The transaction was subject to approval from the Competition Commission of India, as required under applicable regulations. 

About the Company 

Apollo Hospitals Enterprise Limited is one of India’s leading integrated healthcare service providers, with a strong presence across hospitals, clinics, pharmacies, diagnostics, and preventive healthcare.  

The company operates a large hospital network across India and overseas, offering tertiary and quaternary care services, and continues to expand its healthcare ecosystem through strategic investments and subsidiaries. 

Read More: Apollo Hospitals Share Price in Focus; Reports Q2FY26 Results with 26% Rise in Profit! 

Apollo Hospitals Share Price Performance  

As of January 22, 2026, at 10:45 AM, Apollo Hospitals share price is trading at ₹6,858 per share, reflecting a surge of 0.46% from the previous closing price. Over the past month, the stock has declined by 2.78%. 

Conclusion  

The approval strengthens Apollo Hospitals’ position in its healthcare subsidiary and reflects regulatory clearance for strategic consolidation. The transaction supports the company’s long-term objective of expanding integrated healthcare services while reinforcing control over Apollo Health and Lifestyle Limited’s operations and growth trajectory. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.  

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.